U.S. FDA clears LensAR ophthalmic laser system for additional utility

April 23, 2018

The approval expands the platform's capabilities to include the creation of the corneal pockets and flaps used in ophthalmic procedures.

Content Dam Bow Online Articles 2018 04 Laserandsmoke Highres Web

Ophthalmic laser system maker LensAR (Orlando, FL) has received U.S. FDA clearance for the its LENSAR Laser System with Streamline IV, expanding the platform's capabilities to include the creation of the corneal pockets and flaps used in ophthalmic procedures for treating presbyopia.

The presbyopia procedure features of the LENSAR Laser System with Streamline IV include a new curved contact patient interface device that enables the creation of corneal pockets and flaps without compromising patient comfort.

LensAR receives U.S. FDA clearance for the LENSAR Laser System with Streamline IV to perform corneal pockets and flaps used in corneal inlay procedures for treating presbyopia. (Photo: Business Wire)

The new presbyopia procedure capabilities will be rolling out to LensAR users in the U.S. in 2018. The company has applied for regulatory approval in the EU and anticipates availability of the new features there later in 2018, pending approval.

For more information, please visit www.lensar.com.